Sustained haematological response to high-dose oral alfacalcidol in patients with myelodysplastic syndromes.
S M
SM
Kelsey
A C
AC
Newland
J
J
Cunningham
H L
HL
Makin
R D
RD
Coldwell
M J
MJ
Mills
I R
IR
Grant
D001769:Blood / Q000187:drug effects*; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000008:administration & dosage*; D008297:Male; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*
D006887:Hydroxycholecalciferols; C008088:alfacalcidol